Tillotts Pharma Ag
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Subsidiary
- Established
- 1986-01-01
- Employees
- 501
- Market Cap
- -
- Website
- http://www.tillotts.com
Clinical Trials
28
Active:15
Completed:13
Trial Phases
2 Phases
Phase 1:18
Phase 3:8
Drug Approvals
25
CANADA:7
NMPA:4
CIMA_AEMPS:4
+2 more agencies
Drug Approvals
Mesalazine Enteric-coated Tablets
- Product Name
- 美沙拉嗪肠溶片
- Approval Number
- 国药准字HJ20200006
- Approval Date
- Apr 15, 2025
NMPA
Mesalazine Enteric-coated Tablets
- Product Name
- 美沙拉嗪肠溶片
- Approval Number
- 国药准字HJ20200007
- Approval Date
- Apr 15, 2025
NMPA
Mesalazine Enteric-coated Tablets
- Product Name
- 美沙拉嗪肠溶片
- Approval Number
- H20200007
- Approval Date
- Apr 23, 2020
NMPA
Mesalazine Enteric-coated Tablets
- Product Name
- 美沙拉嗪肠溶片
- Approval Number
- H20200006
- Approval Date
- Apr 23, 2020
NMPA
Clinical Trials
Distribution across different clinical trial phases (26 trials with phase data)• Click on a phase to view related trials
Phase 1
18 (69.2%)Phase 3
8 (30.8%)Pharmaco-Scintigraphic Study to Evaluate the Release Profile of Metronidazole Benzoate Capsules
- First Posted Date
- 2016-09-22
- Last Posted Date
- 2017-04-04
- Lead Sponsor
- Tillotts Pharma AG
- Target Recruit Count
- 18
- Registration Number
- NCT02911298
- Locations
- 🇨🇭
University Hospital Basel, Phase I Research Unit, Basel, Basel-Stadt, Switzerland
TP0501 - Pharmaco-Scintigraphic-Study
Phase 1
Completed
- Conditions
- Ulcerative Colitis
- Interventions
- Drug: TP05 Coating ADrug: TP05 Coating B
- First Posted Date
- 2014-12-03
- Last Posted Date
- 2014-12-03
- Lead Sponsor
- Tillotts Pharma AG
- Target Recruit Count
- 18
- Registration Number
- NCT02306772
TP0502-Pharmaco-Scintigraphic-Study and Amendment
Phase 1
Completed
- Conditions
- Ulcerative Colitis
- Interventions
- Drug: TP05 Coating DDrug: TP05 Coating HDrug: TP05 Coating E
- First Posted Date
- 2014-12-03
- Last Posted Date
- 2014-12-03
- Lead Sponsor
- Tillotts Pharma AG
- Target Recruit Count
- 26
- Registration Number
- NCT02306785
TP0502-B-Pharmaco-Scintigraphic-Study
- First Posted Date
- 2014-12-03
- Last Posted Date
- 2014-12-04
- Lead Sponsor
- Tillotts Pharma AG
- Target Recruit Count
- 9
- Registration Number
- NCT02306798
TP05 for the Treatment of Mild to Moderate Active Ulcerative Colitis (UC)
- First Posted Date
- 2013-07-19
- Last Posted Date
- 2018-08-08
- Lead Sponsor
- Tillotts Pharma AG
- Target Recruit Count
- 817
- Registration Number
- NCT01903252
- Locations
- 🇨🇭
Tillotts Pharma AG, Rheinfelden, Baslerstrasse 15, Switzerland
- Prev
- 1
- 2
- Next
News
No news found